EP
TECH icon

Eversept Partners’s Bio-Techne TECH Stock Holding History

Eversept Partners’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.58M Sell
125,896
-251,509
-67% -$15.1M 0.35% 55
2025
Q4 		$22.2M Sell
377,405
-214,135
-36% -$13M 1.12% 22
2025
Q3 		$32.9M Buy
591,540
+197,401
+50% +$10.6M 2.27% 16
2025
Q2 		$20.3M Buy
394,139
+114,022
+41% +$5.73M 1.87% 16
2025
Q1 		$16.4M Sell
280,117
-19,193
-6% -$1.3M 1.67% 21
2024
Q4 		$21.6M Sell
299,310
-364,263
-55% -$26.7M 1.91% 12
2024
Q3 		$53M Buy
663,573
+120,529
+22% +$9.06M 3.63% 11
2024
Q2 		$38.9M Sell
543,044
-64,643
-11% -$4.76M 2.66% 12
2024
Q1 		$42.8M Buy
607,687
+142,380
+31% +$10.2M 2.85% 10
2023
Q4 		$35.9M Buy
465,307
+79,418
+21% +$5.23M 3.15% 9
2023
Q3 		$26.3M Buy
385,889
+43,252
+13% +$3.42M 2.22% 10
2023
Q2 		$28M Buy
342,637
+153,978
+82% +$12.4M 2.34% 10
2023
Q1 		$14M Buy
188,659
+172,024
+1,034% +$13.3M 0.98% 22
2022
Q4 		$1.38M Buy
+16,635
New +$1.32M 0.12% 54
2022
Q2 		– Sell
-4,248
Closed -$460K – 98
2022
Q1 		$460K Buy
+4,248
New +$438K 0.04% 78

Other funds holding TECH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Eversept Partners's TECH Position: Q1 2026 in Review

Eversept Partners reduced its Bio-Techne (TECH) stake by 67% in Q1 2026, selling an estimated $15.1M and leaving 125,896 shares worth $6.58M. The position accounts for 0.35% of the portfolio, ranked #55.

Eversept Partners first reported a position in TECH in Q1 2022 and has held it in 15 quarters since. The position peaked at $53M in Q3 2024. 582 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • Eversept Partners held 125,896 shares of Bio-Techne worth $6.58M as of Q1 2026.
  • Eversept Partners sold 251,509 Bio-Techne shares in Q1 2026, an estimated $15.1M.
  • Bio-Techne made up 0.35% of Eversept Partners's portfolio in Q1 2026, its #55 holding.
  • Eversept Partners first reported a position in Bio-Techne in Q1 2022 and has held it in 15 quarters since.
  • Eversept Partners's Bio-Techne position peaked at $53M in Q3 2024.
  • 582 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Eversept Partners's 13F filing for Q1 2026, filed 15 May 2026.